NASDAQ:SGRY Surgery Partners Q2 2026 Earnings Report $16.41 +0.83 (+5.33%) Closing price 04:00 PM EasternExtended Trading$16.40 0.00 (-0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Surgery Partners EPS ResultsActual EPSN/AConsensus EPS $0.02Beat/MissN/AOne Year Ago EPSN/ASurgery Partners Revenue ResultsActual RevenueN/AExpected Revenue$830.03 millionBeat/MissN/AYoY Revenue GrowthN/ASurgery Partners Announcement DetailsQuarterQ2 2026Date8/10/2026TimeBefore Market OpensConference Call DateMonday, August 10, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Surgery Partners Earnings HeadlinesSurgery Partners announces $1.15B deal to sell stakes in Idaho Falls FacilitiesJuly 24, 2026 | seekingalpha.comSurgery Partners Announces Agreement to Sell Idaho Falls Hospital Interests to Intermountain Health for $795 MillionJuly 24, 2026 | quiverquant.comQBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.July 29 at 1:00 AM | Chaikin Analytics (Ad)Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of TransactionJuly 24, 2026 | globenewswire.comSurgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative BuildsJuly 11, 2026 | finance.yahoo.comUnpacking Q1 earnings: Surgery Partners (NASDAQ:SGRY) in the context of other outpatient & specialty care stocksJune 19, 2026 | msn.comSee More Surgery Partners Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Surgery Partners? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surgery Partners and other key companies, straight to your email. Email Address About Surgery PartnersSurgery Partners (NASDAQ:SGRY) operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation. Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care. The company deploys a capital-light management services model as well as joint-venture ownership structures to develop and acquire facilities in mid-sized and underserved markets. As of the most recent disclosures, Surgery Partners maintains operations in more than 25 states, serving patients through over 200 ambulatory surgery centers and multiple inpatient surgical and rehabilitation hospitals. Headquartered in Nashville, Tennessee, Surgery Partners emphasizes clinical governance and regulatory compliance, leveraging standardized protocols to drive quality outcomes and operational efficiency. The leadership team is led by President and Chief Executive Officer Douglas Coltharp, who brings extensive experience in healthcare strategy, capital markets and operations. Under Coltharp’s guidance, the company continues to pursue selective growth opportunities while maintaining collaborative relationships with physician partners and payors to address the evolving demands of value-based care.View Surgery Partners ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why SK hynix Could Be the Best AI Chip Stock to Buy NowWhy Bloom Energy May Be the Most Important AI Infrastructure StockAlphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?Seagate Technology Stock Surges as Earnings Beat Silences AI DoubtersCarrier Earnings Could Send the Stock to a New All-Time High3 Refiners Benefiting From Oil Volatility and Tight Fuel SupplyWelltower at 52-Week Highs—But Analysts Believe There's More to Come Upcoming Earnings Ferrari (7/30/2026)Air Products and Chemicals (7/30/2026)ArcelorMittal (7/30/2026)Vale (7/30/2026)Mastercard (7/30/2026)Apple (7/30/2026)ASE Technology (7/30/2026)Monolithic Power Systems (7/30/2026)CRH (7/30/2026)Quanta Services (7/30/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
